Search for: "AstraZeneca Inc." Results 141 - 160 of 340
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Jun 2015, 3:57 am by Derek T. Braslow
Among the PPIs identified in the study as linked to an increased risk of heart attack, the following are common in prescription or over- the-counter form: • Prilosec – manufactured by AstraZeneca • Prilosec OTC – manufactured by Procter & Gamble • Nexium – manufactured by AstraZeneca and now available over the counter • Zegerid OTC – manufactured by Merck & Col and Santarus, Inc. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva,… [read post]
29 Jul 2008, 6:52 pm
Bigband Networks, Inc., a U.K. citizen who resides in Cyprus was appointed lead plaintiff in a class action under the Securities Act involving an IPO in the U.S.; while in Corwin v. [read post]
27 Jul 2020, 2:04 am by Deb Givens
., AbCellera Biologics, Amgen Inc., AstraZeneca, Genentech and GlaxoSmithKline to share information about producing the antibody treatments needed to treat COVID-19. [read post]
29 Nov 2011, 11:24 am by fraudfighters
  Some other recent settlements have been paid by GlaxoSmithKline, Pfizer Inc., Eli Lilly & Co., and AstraZeneca. [read post]
3 May 2007, 5:45 am
"New DealsThursday, May 3, 2007By Janine Friend"London-based AstraZeneca plc has agreed to buy MedImmune for a total of $15.2 billion. [read post]
1 Jul 2010, 1:32 pm by Richard Renner
Grassley letters are available in the continuation of this blog entryBelow are links to the letters sent by Grassley to: Abbott Laboratories Amgen AstraZeneca Pharmaceuticals Boehringer Bristol-Myers Squibb Company Eisai Corporation of America Eli Lilly and Company Forest Laboratories GlaxoSmithKline Hoffman-La Roche Inc. [read post]
8 Oct 2009, 6:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Seroquel (Quetiapine) – US: CAFC: Sometimes, sins of omission are not inequitable conduct: AstraZeneca Pharmaceuticals LP v. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
20 Nov 2012, 7:50 am
* On Thursday 6 December, judgment will be given in Case C‑457/10 P AstraZeneca AB and Astra Zeneca plc v European Commission. [read post]